*
Corresponding authors
a
Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
E-mail:
dong.525@osu.edu
b
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
E-mail:
dgander@mit.edu
c
Department of Anesthesiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA
d
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
e
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
f
Department of Biotechnology and Food Engineering, Technion Institute of Technology and the Russell Berrie Nanotechnology Institute, Haifa 32000, Israel
g
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
h
Department of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA
i
The Center for Clinical and Translational Science, The Ohio State University, Columbus, OH 43210, USA
j
The Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA